Law360, New York (July 23, 2010, 3:30 PM ET) -- The U.S. Senate has abandoned an amendment sent to it by the House of Representatives that would have limited pharmaceutical companies' ability to enter into legal agreements to delay the market introduction of generic drugs.
Senators failed to muster the 60 votes needed to close debate on a package of amendments to H.R. 4899, the Emergency Supplemental Appropriations Act, on Thursday night. Following a failed 46-51 vote to reach cloture, the Senate unanimously consented to send the original appropriations bill back to the House without the...
Senate Strips Pay-For-Delay Ban From Spending Bill
To view the full article, take a free trial now.
